Share on X dbeard @dominionpost.com MORGANTOWN — A groundbreaking new drug that could revolutionize the treatment of opioid use disorder was developed here in ...

BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announces the launch of Derisq™, ...

The research was a collaborative effort led by Dr. Christie D. Fowler and her team at UCI’s Department of Neurobiology and Behavior, alongside GATC Health’s drug discovery team. By integrating GATC’s ...

Add Yahoo as a preferred source to see more of our stories on Google. Jan. 21—MORGANTOWN — GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new cancer drug in development ...

GATC Health Corp. has partnered with Medical and Commercial International Limited (MCI), a liability underwriting company in London, to create the first insurance policy for clinical trials. Now ...

Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development. The collaboration aims to expedite and enhance the success rates of ...

An Irvine-based startup is trying to convince investors that it can use artificial intelligence to dramatically reduce the time needed to show if a drug can work in a clinical trial. GATC Health Corp.

Expanded alliance combines Lisata’s drug development expertise with GATC’s AI-powered Multiomics Advanced Technology® platform to accelerate and improve success rates of next-generation drug ...

IRVINE, Calif.--(BUSINESS WIRE)--GATC Health, an innovative technology company focused on whole genome testing and Predictive Multiomics™, today announced that it has granted an exclusive license for ...

Strategic collaboration harnesses GATC’s proprietary Artificial Intelligence-powered, validated Multiomics Advanced Technology™ platform to rapidly optimize and derisk drug discovery and development, ...

IRVINE, Calif.--(BUSINESS WIRE)--GATC Health, a pioneering technology company focused on whole genome testing and Predictive Multiomics™, and Liquid Biosciences, a leader in predictive algorithms and ...

Boston — “If we want to treat and cure all disease, that will require enabling genetic agency,” said Eric Kelsic, PhD, co-founder and CEO of Dyno Therapeutics, in an interview with GEN. “AI will have ...